CTVA vs RANI · P/E 42, rev $16.91B vs rev $3.4M
Corteva Inc (CTVA) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. RANI currently screens at market cap $41.5M.
Not investment advice. Open the CTVA and RANI stock pages for the full models.
Not investment advice.